Impel NeuroPharma

Impel NeuroPharma

Impel NeuroPharma

Seattle-based Impel NeuroPharma was founded with a mission to enable drugs to bypass the blood brain barrier.
Founded
2008
Raised
$107.8M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$67,500,000
Venture capital - 2018
$36,000,000
Venture capital (Series C) - 2016
5AM Ventures venBio Vivo Capital
Team Size
10+
Employees
FinSMEs

Impel NeuroPharma Closes $67.5M in Series D Financing

$67,500,000 Venture capital
GeekWire , PE HUB

Seattle biotech scores $67.5M to treat migraines and Parkinson’s with drugs delivered deep into the nasal cavity

$36,000,000 Venture capital (Series C)
GeekWire , FinSMEs

Impel NeuroPharma raises $36M for drug delivery platform that bypasses blood-brain barrier

Health